Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Spectrum Pharmaceuticals

Spectrum Pharmaceuticals Announces New Employment Inducement Grant for Commercial Staff
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals Announces New Employment Inducement Grants for Commercial Staff
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals Provides Update on Poziotinib Following FDA Oncologic Drugs Advisory Committee Meeting
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals to Report First Quarter 2022 Financial Results and Provide Corporate Update
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals Appoints Brittany K. Bradrick to Board of Directors
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals Announces Acceptance of New Drug Application Filing for Poziotinib
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals to Participate in B. Riley Securities 2022 Virtual Oncology Conference
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals Announces Strategic Restructuring
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals to Participate in JMP Securities Hematology and Oncology Summit
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals to Participate in 2021 Jefferies London Healthcare Conference
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals to Report Third Quarter 2021 Financial Results and Provide Corporate Update
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals to Participate in 2021 Cantor Virtual Global Healthcare Conference
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals Announces Late-Breaking Oral Presentation of Data for Poziotinib in First-Line NSCLC Patients with HER2 Exon 20 Mutations at the Upcoming ESMO Congress 2021
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for ROLONTIS® (eflapegrastim)
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals to Report Second Quarter 2021 Financial Results and Provide Corporate Update
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals Presents Poziotinib Data in Patients with Brain Metastases from the ZENITH20 Clinical Trial at 2021 ASCO Annual Meeting
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals Announces That the ROLONTIS® (eflapegrastim) Pre-Approval Inspection Has Been Initiated
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals to Present Data for Poziotinib in Patients with Brain Metastases at the Upcoming 2021 ASCO Annual Meeting
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals to Participate in Two Upcoming Investor Conferences in June
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals Presents Additional Twice Daily Dosing Data for Poziotinib at the AACR Virtual Meeting 2021
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.